INTRODUCTION
The occurrence of resistant S. mansoni strains has been reported by several investigators 2 . 3 -6 . In a study on the behavior of a Brazilian strain (MAP) of the worm towards schistosomicidal drugs, were observed that progenies F 1 to F 5 were resistant to oxamniquine and hycanthone but sensitive to niridazole and praziquantel 3 . The patient (MAP) from whom the strain was isolated was treated once with hycanthone and twice with oxamniquine, with no parasitologic cure.
To evaluate the stability of the susceptibility of the MAP strain, an experimental therapeutic trial was carried out with the F 14 progeny.
In the present study we utilized a new drug, Oltipraz (35,972 RP), a new schistosomicidal drug that has been already tested in clinical trials'A
MATERIAL AND METHODS
After a previous study, we have been maintaining the MAP strain in our laboratory without exposure to schistosomicidal drugs by the following transfer scheme: Biomphalaria glabrata -mice -Biomphalaria glabrata. F 14 Cercariae obtained from B. glabrata snails were used to infect female albino mice (Swiss), by the tail immersion technique 9 . Each mouse was exposed to 100 cercariae. Drug treatment was carried out as follows 45 days after cercarial infection: 1 x 80 mg/kg hycanthone, intramuscularly; 1 x 100 mg/kg oxamniquine; 5 x 100 mg/kg/day niridazole; 5 x 100 The mice were killed with a blow on the neck 10 days after treatment and the worms recovered by perfusion 9. The schistosomicidal action was evaluated by the distribution of worms in the mesenteric vessels, percentage of mice with oogram changes and percentage of parasite reduction W.
RESULTS
We noticed that there was a high percen tage of male worms in almost all groups, spe cially in that treated with oxamniquine. We could also observe (Table I) the existence of two different patterns obtained by the thera peutic evaluation.
In the first pattern, represented by the groups treated with praziquantel, niridazole and Oltipraz we found a low percentage of worms in the mesenteric veins, 100% of altered oograms, and a high percentage of parasite re duction.
In the second pattern, showed by the groups treated with hycanthone and oxamni quine, the findings consisted by a greater amount of worms in the mesenteric veins, no alterations in the oograms, and a low percen tage of parasite reduction.
The data of the first pattern have demons trate some susceptibility to the antischistosomal used against those groups of worms, by the other hand the results obtained in the second pattern were very similar to the control group, confirming the worm resistance to the oxam niquine and hycanthone.
One of the most important criteria to be evaluated in experimental analysis of suscepti bility, in relation to antischistosomal drugs against S. mansoni is the percentage of para site reduction, since the surviving worms are the responsable by the therapeutic failure and potentially able to produce resistance progenies to this drugs 5 . 10 .
Although cercarían infection was perform ed on groups of 12 mice, it was not always pos sible to treat the same number of animals be cause of mortality during the 45-day period proceeding drug administration.
Worm mortality was not detected in the control group.
DISCUSSION
In the 14th progeny of the MAP strain, worm resistance remained stable when com pared to the 1st to 5th progeny with respect to hycanthone and oxamniquine. The strain also showed stability of the susceptibility to niri dazole and praziquantel.
In the present study, Oltipraz, which was being used for the first time against the MAP strain, showed clear activity. No cross-resis tance with the other drugs studied here was shown by Oltipraz.
An interesting fact occurred in the present experiment.
A relatively high percentage of male worms occurred in the infections especialty in the group of mice treated with oxamniquine. Some investigators demonstrated that in infections by males only, most worms tend to be localized in the liver and portal vein n> 12 . In the present study, although most of the worms were located in the liver and portal vein, in the animals treated with oxamniquine it could be seen that, when other parameters were utilized, the worms were resistant to the drug. However, the importance of well-balanced bisexual infections should be emphasized for the correct analysis of susceptibility to schistosomicidal drugs when the criterion of worm distribution is used.
CONCLUSIONS
In conclusion, our results show that: (a) the resistance and susceptibility to four drugs of an S. mansoni strain were stable in the F M progeny "when compared to generations Pj to F 5 ; (b) a new drug, Oltipraz, tested only on progeny F 14 , was shown to be effective, 'with no cross-resistance with hycanthone and oxamniquine.
RESUMO Estabilidade de progênie de Schistosoma mansoni a drogas esquistossomicidas
A suscetibilidade de linhagem brasileira (MAP), nas gerações F 1 a F 5 de S. mansoni a quatro drogas esquistossomicidas foi descrita em trabalho anterior. Na presente pesquisa os Autores testam a estabilidade da progênie F 14 da referida linhagem às quatro drogas e a um novo medicamento, Oltipraz (35,972 RP). Cinco grupos de 12 camundongos infectados com cercarias por meio da imersão da cauda, foram tratados com hycanthone, oxamniquine, nirida¬ zole, praziquantel e Oltipraz. Foi utilizado um grupo controle de camundongos infectados e não tratados.
A atividade esquistossomicida das drogas foi avaliada pela localização dos vermes no sistema porta, pelas alterações no oograma e percentagem de redução de vermes. A suscetibilidade dos vermes da geração F 14 mostrou-se estável em relação àquelas observadas nas progénies F 1 a F 5 ; a progênie F 14 de vermes foi resistente ao hycanthone e oxamniquine; todavia, for sensível ao niridazole, praziquantel e Oltipraz. Os Autores enfatizam a importância do fenômeno de resistência do verme em vista do fato do oxamniquine ser largamente utilizado em áreas do Brasil onde a esquistossomose mansônica é endêmica.
